talquetamab
janssen
['multiplemyeloma', 'talquetamab']
starting off day 2 of #eha2023 with albert oriol ( ), who spoke to us about the comparative effectiveness of talquetamab vs physician s choice therapy in patients with triple-class exposed r/r #myeloma. #hemonc #multiplemyeloma 
The Video Journal of Hematological Oncology is dedicated to providing up-to-date information & international expertise on #HemOnc #LeuSM
#LymSM #MMsm #MPN #MDS